Incyte (INCY)
$120.39 +3.07% Close Oct 30, 2026 Live
Incyte stock today
Incyte closed at $120.39 on October 30, 2026, up 3.07% on the day. Over the past year it returned +30.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $24.4 billion.
$100.00$120.00
NovJan 2026MarMayJulSep
| Period | INCY | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.8% | -0.9% |
| 3 months | -2.1% | +2.1% |
| Year to date | +21.9% | +11.7% |
| 1 year | +30.0% | +12.4% |
| 3 years | +130.8% | +88.5% |
| 5 years | +79.7% | +76.0% |
Key statistics
- Market value
- $24.4B
- P/E (trailing)
- 64.0
- Forward P/E
- 16.2
- Price / sales
- 4.1
- 52-week range
- $90.30 to $129.93
About Incyte
Incyte develops and commercializes oncology and inflammation-related pharmaceutical products.
Sector: Health Care · Industry: Biotechnology
More on Incyte
- Financials: revenue, earnings and segmentsRevenue +21% in the year to Dec 2025
- Valuation: P/E history and peersP/E 64.0, median 47.7 at its last 8 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,382 today
No forecast, no recommendation. This page describes Incyte from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.